British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …
Both represent chronic inflammation of the gastrointestinal tract, which displays …
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase
worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease …
worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease …
Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease
LM Chen, CH Bao, Y Wu, SH Liang, D Wang… - Journal of …, 2021 - Springer
Inflammatory bowel disease (IBD), which mainly includes ulcerative colitis (UC) and Crohn's
disease (CD), is a group of chronic bowel diseases that are characterized by abdominal …
disease (CD), is a group of chronic bowel diseases that are characterized by abdominal …
The necessity–concerns framework predicts adherence to medication in multiple illness conditions: A meta-analysis
Objective This meta-analysis investigated whether beliefs in the necessity and concerns of
medicine and the necessity–concerns differential are correlated with medication adherence …
medicine and the necessity–concerns differential are correlated with medication adherence …
[HTML][HTML] Medication adherence in inflammatory bowel disease
W Chan, A Chen, D Tiao, C Selinger… - Intestinal …, 2017 - synapse.koreamed.org
Inflammatory bowel disease (IBD) is a chronic idiopathic inflammatory condition with
intestinal and extraintestinal manifestations. Medications are the cornerstone of treatment of …
intestinal and extraintestinal manifestations. Medications are the cornerstone of treatment of …
A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases
E Vangeli, S Bakhshi, A Baker, A Fisher, D Bucknor… - Advances in …, 2015 - Springer
Background Non-adherence impacts negatively on patient health outcomes and has
associated economic costs. Understanding drivers of treatment adherence in immune …
associated economic costs. Understanding drivers of treatment adherence in immune …
[HTML][HTML] Selective JAK1 inhibitors for the treatment of inflammatory bowel disease
Janus kinase (JAK) inhibitors, also known as jakinibs, are third-generation oral small
molecules that have expanded the therapeutic options for the management of chronic …
molecules that have expanded the therapeutic options for the management of chronic …
Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?
Depressive symptoms are reported by more than 20% of people with inflammatory bowel
disease (IBD), while sleep difficulties and fatigue are even more common. Co-morbid …
disease (IBD), while sleep difficulties and fatigue are even more common. Co-morbid …
JAK1 inhibition and inflammatory bowel disease
C Harris, JRF Cummings - Rheumatology, 2021 - academic.oup.com
Primary non-response and secondary loss of response remain a significant issue with the
currently available treatment options for a significant proportion of patients with inflammatory …
currently available treatment options for a significant proportion of patients with inflammatory …
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
Methods To construct this review article, we performed a systematic review of the literature to
identify relevant studies comparing anti-TNF monotherapy to combination therapy with an …
identify relevant studies comparing anti-TNF monotherapy to combination therapy with an …